March 25, 2025 | Vensana Capital® Portfolio News

Evident Vascular Raises Series B Financing to Advance AI-Powered Intravascular Ultrasound Platform Technology

21

Novel FDA PMA & de novo 510k approvals

60

U.S. Commercial Product Launches

40

Level I Clinical Trials

32

Strategic Financings

31

Exits by IPO or M&A